Cookie Settings
We use cookies to provide the best possible website experience for you. This includes cookies that are technically required to ensure a proper functioning of the website, as well as cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for displaying personalized content. You are free to choose the categories you would like to permit. Please note that depending on your settings, the full functionality of the website may no longer be available. Further information can be found in our Privacy Statement and Cookie Statement.
PBMCs were stimulated with PMA and Ionomycin or left untreated. Cells were stained according to secretion of IL-22 using the IL-22 Secretion Assay - Cell Enrichment and Detection Kit (PE), human. Displayed is the analysis of secreted IL-22 (PE) versus CD154-APC of viable CD4 + T cells (gated on CD4-FITC). B cells, monocytes, and dead cells were excluded according to CD20-PerCP, CD14-PerCP, and PI-staining respectively. |
Stimulated sample |
Before enrichment | After enrichment |
IL-22 Secretion Assay – Cell Enrichment and Detection Kit (PE), humanFigure 1PBMCs were stimulated with PMA and Ionomycin or left untreated. Cells were stained according to secretion of IL-22 using the IL-22 Secretion Assay - Cell Enrichment and Detection Kit (PE), human. Displayed is the analysis of secreted IL-22 (PE) versus CD154-APC of viable CD4 + T cells (gated on CD4-FITC). B cells, monocytes, and dead cells were excluded according to CD20-PerCP, CD14-PerCP, and PI-staining respectively. | IL-22 Secretion Assay – Cell Enrichment and Detection Kit (PE), humanFigure 1PBMCs were stimulated with PMA and Ionomycin or left untreated. Cells were stained according to secretion of IL-22 using the IL-22 Secretion Assay - Cell Enrichment and Detection Kit (PE), human. Displayed is the analysis of secreted IL-22 (PE) versus CD154-APC of viable CD4 + T cells (gated on CD4-FITC). B cells, monocytes, and dead cells were excluded according to CD20-PerCP, CD14-PerCP, and PI-staining respectively. |
Unstimulated control |
Before enrichment | After enrichment |
IL-22 Secretion Assay – Cell Enrichment and Detection Kit (PE), humanFigure 1PBMCs were stimulated with PMA and Ionomycin or left untreated. Cells were stained according to secretion of IL-22 using the IL-22 Secretion Assay - Cell Enrichment and Detection Kit (PE), human. Displayed is the analysis of secreted IL-22 (PE) versus CD154-APC of viable CD4 + T cells (gated on CD4-FITC). B cells, monocytes, and dead cells were excluded according to CD20-PerCP, CD14-PerCP, and PI-staining respectively. | IL-22 Secretion Assay – Cell Enrichment and Detection Kit (PE), humanFigure 1PBMCs were stimulated with PMA and Ionomycin or left untreated. Cells were stained according to secretion of IL-22 using the IL-22 Secretion Assay - Cell Enrichment and Detection Kit (PE), human. Displayed is the analysis of secreted IL-22 (PE) versus CD154-APC of viable CD4 + T cells (gated on CD4-FITC). B cells, monocytes, and dead cells were excluded according to CD20-PerCP, CD14-PerCP, and PI-staining respectively. |
PBMCs were stimulated with PMA and Ionomycin or left untreated. Cells were stained according to secretion of IL-22 using the IL-22 Secretion Assay - Cell Enrichment and Detection Kit (PE), human. Displayed is the analysis of secreted IL-22 (PE) versus CD154-APC of viable CD4 + T cells (gated on CD4-FITC). B cells, monocytes, and dead cells were excluded according to CD20-PerCP, CD14-PerCP, and PI-staining respectively. |
Stimulated sample |
Before enrichment | After enrichment |
IL-22 Secretion Assay – Cell Enrichment and Detection Kit (PE), humanFigure 1PBMCs were stimulated with PMA and Ionomycin or left untreated. Cells were stained according to secretion of IL-22 using the IL-22 Secretion Assay - Cell Enrichment and Detection Kit (PE), human. Displayed is the analysis of secreted IL-22 (PE) versus CD154-APC of viable CD4 + T cells (gated on CD4-FITC). B cells, monocytes, and dead cells were excluded according to CD20-PerCP, CD14-PerCP, and PI-staining respectively. | IL-22 Secretion Assay – Cell Enrichment and Detection Kit (PE), humanFigure 1PBMCs were stimulated with PMA and Ionomycin or left untreated. Cells were stained according to secretion of IL-22 using the IL-22 Secretion Assay - Cell Enrichment and Detection Kit (PE), human. Displayed is the analysis of secreted IL-22 (PE) versus CD154-APC of viable CD4 + T cells (gated on CD4-FITC). B cells, monocytes, and dead cells were excluded according to CD20-PerCP, CD14-PerCP, and PI-staining respectively. |
Unstimulated control |
Before enrichment | After enrichment |
IL-22 Secretion Assay – Cell Enrichment and Detection Kit (PE), humanFigure 1PBMCs were stimulated with PMA and Ionomycin or left untreated. Cells were stained according to secretion of IL-22 using the IL-22 Secretion Assay - Cell Enrichment and Detection Kit (PE), human. Displayed is the analysis of secreted IL-22 (PE) versus CD154-APC of viable CD4 + T cells (gated on CD4-FITC). B cells, monocytes, and dead cells were excluded according to CD20-PerCP, CD14-PerCP, and PI-staining respectively. | IL-22 Secretion Assay – Cell Enrichment and Detection Kit (PE), humanFigure 1PBMCs were stimulated with PMA and Ionomycin or left untreated. Cells were stained according to secretion of IL-22 using the IL-22 Secretion Assay - Cell Enrichment and Detection Kit (PE), human. Displayed is the analysis of secreted IL-22 (PE) versus CD154-APC of viable CD4 + T cells (gated on CD4-FITC). B cells, monocytes, and dead cells were excluded according to CD20-PerCP, CD14-PerCP, and PI-staining respectively. |
Seems like you are coming from USA!
Do you want to visit our website in your country?
Copyright © 2023 Miltenyi Biotec and/or its affiliates. All rights reserved.